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Summary 21 
Parathyroid hormone (PTH) stimulates adenylyl cyclase (AC) via type 1 PTH receptors 22 
(PTH1R) and potentiates the Ca
2+
 signals evoked by carbachol, which stimulates formation of 23 
IP3. We confirmed that in HEK cells expressing PTH1R, acute stimulation with PTH(1-34) 24 
potentiated carbachol-evoked Ca
2+
 release. This was mediated by locally delivered cyclic 25 
AMP (cAMP), but unaffected by inhibition of protein kinase A (PKA), exchange proteins 26 
activated by cAMP, cAMP phosphodiesterases (PDE) or substantial inhibition of AC. 27 
Sustained stimulation with PTH(1-34) causes internalization of PTH1R-AC signalling 28 
complexes, but the consequences for delivery of cAMP to IP3R within cAMP signalling 29 
junctions are unknown. Here we show that sustained stimulation with PTH(1-34) or with 30 
PTH analogues that do not evoke receptor internalization reduced the potentiated Ca
2+
 signals 31 
and attenuated carbachol-evoked increases in cytosolic IP3. Similar results were obtained 32 
after sustained stimulation with NKH477 to directly activate AC, or with the membrane-33 
permeant analogue of cAMP, 8-Br-cAMP. These responses were independent of PKA and 34 
unaffected by substantial inhibition of AC. During prolonged stimulation with PTH(1-34), 35 
hyperactive cAMP signalling junctions, within which cAMP is delivered directly and at 36 
saturating concentrations to its targets, mediate sensitization of IP3R and a more slowly 37 
developing inhibition of IP3 accumulation.  38 
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Introduction 39 
Parathyroid hormone (PTH) is the major endocrine regulator of plasma Ca
2+
 and phosphate 40 
concentrations and, with PTH-related peptide (PTHrP), it regulates bone remodelling (Potts 41 
and Gardella, 2007). Many effects of PTH and PTHrP are mediated by type 1 PTH receptors 42 
(PTH1R), which are G-protein-coupled receptors (GPCR) (Mahon, 2012; Mannstadt et al., 43 
1999). PTH receptors, along with other class II GPCRs, stimulate both adenylyl cyclase (AC) 44 
activity and an increase in the cytosolic free Ca
2+ 
concentration ([Ca
2+
]c) (Taylor and Tovey, 45 
2012). The N-terminal fragments of PTH and PTHrP, PTH(1-34) and PTHrP(1-36), are 46 
sufficient for activation of PTH1R (Mahon, 2012). However,  PTH analogues differ in 47 
whether they favour PTH1R coupling to G proteins or other signalling proteins, notably 48 
GPCR kinases and β-arrestins (Dean et al., 2008; Gesty-Palmer and Luttrell, 2011; Okazaki 49 
et al., 2008). Binding of β-arrestin to PTH1R contributes to desensitization (Feinstein et al., 50 
2011), but it also recruits additional signalling pathways (Gesty-Palmer et al., 2006) and 51 
initiates internalization of active PTH1R·Gs·AC signalling complexes via β-arrestin- and 52 
dynamin-dependent endocytosis (Ferrandon et al., 2009; Gidon et al., 2014). These 53 
complexes then continue to generate cAMP from early endosomal compartments (Feinstein 54 
et al., 2011; Ferrandon et al., 2009; Wehbi et al., 2013). Similar agonist-evoked 55 
internalization of functional signalling pathways occurs for some other GPCRs (Calebiro et 56 
al., 2010; Irannejad et al., 2013). The significance for the present work is that internalized 57 
PTH1R signalling complexes and those at the plasma membrane may deliver cAMP to 58 
different intracellular compartments. 59 
 The links between cAMP and Ca
2+
 signalling by PTH1R are complex (Taylor and Tovey, 60 
2012). In most, though not all, cells (Mahon, 2012), PTH1R activates Gs, stimulation of AC 61 
and so formation of cAMP. When PTH1R or Gq is expressed at high levels, PTH1R can also 62 
stimulate phospholipase C (PLC) (Taylor and Tovey, 2012), which catalyses formation of 63 
inositol 1,4,5-trisphosphate (IP3), and so Ca
2+
 release from intracellular stores. Typically, 64 
such Ca
2+ 
signals are evoked by higher concentrations of PTH than are required for 65 
stimulation of AC (Cupp et al., 2013; Okazaki et al., 2008; Takasu et al., 1999; Taylor and 66 
Tovey, 2012; van der Lee et al., 2013). Furthermore, some analogues of PTH favour coupling 67 
of PTH1R to AC via Gs, while others favour PLC coupling (Cupp et al., 2013; Fujimori et al., 68 
1991; Gesty-Palmer and Luttrell, 2011; Takasu et al., 1999) (supplementary material Table 69 
S1). Association of PTH1R with the scaffold proteins, Na
+
/H
+
 exchange regulatory factors-1 70 
and 2 (NHERF-1 and 2), both of which are expressed in HEK cells (Wang et al., 2010), 71 
favours coupling, via Gq or Gi/o, to PLCβ (Wang et al., 2007). Cyclic AMP can also 72 
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stimulate IP3 formation because binding of cAMP to an exchange protein-activated by cAMP 73 
(EPAC-1) allows it to activate the small G protein, rap 2B, which then stimulates PLCε 74 
(Schmidt et al., 2001). 75 
 We have shown that in HEK cells stably expressing human PTH1R (HEK-PR1 cells), 76 
PTH(1-34) stimulates AC. The cAMP produced directly sensitizes IP3R to the IP3 produced 77 
when receptors, like endogenous M3 muscarinic receptors, stimulate PLC. Hence, 78 
concentrations of PTH(1-34) that do not alone evoke increases in [Ca
2+
]c potentiate the Ca
2+
 79 
signals evoked by carbachol, which activates muscarinic receptors (Short and Taylor, 2000; 80 
Tovey et al., 2008; Tovey et al., 2003; Tovey and Taylor, 2013). This potentiation is 81 
mediated by cAMP, but it requires the cAMP to be delivered at high concentrations from AC 82 
to IP3R within a signalling complex that includes AC6 and IP3R2. Furthermore, from 83 
evidence that even substantial inhibition of AC failed to attenuate signalling from PTH1R to 84 
IP3R, we proposed that within each signalling complex, cAMP is presented at concentrations 85 
more than sufficient to maximally sensitize associated IP3Rs (Tovey et al., 2008). We 86 
describe the AC-IP3R complex as a 'signalling junction' to capture an analogy with the 87 
neuromuscular junction of focally innervated  skeletal muscle (Fig. 1A), where release of 88 
acetylcholine from presynaptic terminals saturates postsynaptic receptors and leads to all-or-89 
nothing contraction of the myofibril. Graded contractions of the muscle then result from 90 
graded recruitment of these all-or-nothing fibrillar responses. Because this mode of signalling 91 
to IP3R requires its close association with AC, we assessed whether the association is 92 
maintained during sustained stimulation with PTH(1-34) when PTH1R signalling pathways 93 
may be reconfigured. We show that sustained stimulation with PTH leads to diminished 94 
potentiation of carbachol-evoked Ca
2+
 signals. This does not require internalization of 95 
PTH1R. We provide evidence that the hyperactive cAMP signalling junctions that mediate 96 
sensitization of IP3R by PTH also cause inhibition of IP3 formation during sustained 97 
stimulation. Our results suggest that delivery of cAMP to its targets within signalling 98 
junctions allows rapid potentiation of IP3R activity followed by a more slowly developing 99 
inhibition of IP3 accumulation.       100 
 101 
Results  102 
PTH potentiates carbachol-evoked Ca
2+
 release via cAMP-mediated sensitization of IP3 103 
receptors 104 
In HEK-PR1 cells, concentrations of PTH(1-34) that did not alone stimulate Ca
2+
 release 105 
potentiated the Ca
2+ 
signals evoked by carbachol (Fig. 1B) (Tovey et al., 2008). The effects of 106 
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PTH(1-34), added 1 min before addition of a submaximal concentration of carbachol (20 107 
μM), were concentration-dependent (Fig. 1C). Similar results, and with similar sensitivity to 108 
PTH(1-34), were obtained using a maximally effective concentration of carbachol 109 
(supplementary material Table S2). 110 
 At the highest concentrations used (>300 nM), PTH(1-34) alone evoked small (< 40 nM) 111 
increases in [Ca
2+
]c (Short and Taylor, 2000) (Fig. 1F) that were unaffected by inhibition of 112 
AC, cyclic nucleotide phosphodiesterases (PDEs), protein kinase A (PKA) or EPACs 113 
(supplementary material Fig. S1, which also illustrates the targets of the inhibitors used). We 114 
do not detect stimulation of PLC by PTH(1-34) in HEK-PR1 cells (Short and Taylor, 2000; 115 
Tovey et al., 2008; Tovey and Taylor, 2013), but in some settings PTH1R can activate Gq and 116 
PLC (see Introduction). We showed previously that an analogue of PTH, PTH(1-31), that 117 
stimulates AC but was thought not to stimulate PLC, mimicked PTH(1-34) by potentiating 118 
carbachol-evoked Ca
2+
 signals (Tovey et al., 2008). Conversely, PTH(3-34), which was 119 
thought to selectively activate Gq (Fujimori et al., 1991; but see Takasu et al., 1999), was 120 
ineffective (Tovey et al., 2008). A recent study challenges the utility of both analogues (Cupp 121 
et al., 2013). In CHO cells expressing PTH1R, PTH(1-31) was indistinguishable from PTH(1-122 
34) in stimulating AC and PLC (Takasu et al., 1999); while PTH(3-34) stimulated AC (with 123 
very low potency), but not PLC (Cupp et al., 2013). In the same study, PTH(2-38) and 124 
Tyr
1
PTH(1-34) were as effective as PTH(1-34) in stimulating AC, but they failed to activate 125 
PLC (Cupp et al., 2013) (supplementary material Table S1). Selective activation of AC by 126 
PTH(2-38) and Tyr
1
PTH(1-34) is consistent with evidence that N-terminal modifications of 127 
PTH attenuate coupling to PLC (Cupp et al., 2013; Takasu et al., 1999). 128 
 In HEK-PR1 cells, PTH(2-38) and Tyr
1
PTH(1-34) mimicked PTH(1-34) in both 129 
stimulating AC and potentiating carbachol-evoked Ca
2+
 signals (Fig. 1C,D, supplementary 130 
material Table S3). Furthermore, the relationship between the change in intracellular cAMP 131 
concentration and the potentiated Ca
2+
 signals was indistinguishable for the three analogues 132 
(Fig. 1E). However, while the highest concentrations of PTH(1-34), PTHrP(1-34) and 133 
PTH(1-31) directly evoked small Ca
2+
 signals, there was no direct response to PTH(2-38) or 134 
Tyr
1
PTH(1-34) (Fig. 1F). These results demonstrate that only analogues reported to stimulate 135 
PLC directly evoked Ca
2+ 
signals, and only at much higher concentrations than are required 136 
to potentiate carbachol-evoked Ca
2+
 signals. All the PTH analogues that stimulated AC also 137 
potentiated carbachol-evoked Ca
2+
 signals. These results reinforce our conclusion that cAMP 138 
mediates the ability of PTH(1-34) to potentiate carbachol-evoked Ca
2+ 
signals (Tovey et al., 139 
2008) (Fig. 1A). That conclusion is consistent with the observation that for all effective PTH 140 
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analogues, potentiation of carbachol-evoked Ca
2+
 signals was invariably evoked by lower 141 
concentrations of PTH (higher pEC50, where pEC50 is the negative log of the half-maximally 142 
effective concentration) than was cAMP accumulation (Fig. 1C,D, supplementary material 143 
Table S3). The Ca
2+
 signals evoked by very high concentrations of PTH(1-34) probably result 144 
from stimulation of PLC. Our inability to detect IP3 formation under these conditions (Tovey 145 
et al., 2008; Tovey and Taylor, 2013) is unsurprising when the Ca
2+ 
signals evoked by PTH 146 
are small and they are detected only under conditions when the IP3-evoked Ca
2+
 release is  147 
also maximally potentiated via the cAMP produced in response to PTH. 148 
 149 
Potentiation of carbachol-evoked Ca
2+
 release by PTH requires neither protein kinase A 150 
nor EPACs  151 
We have provided evidence that the effects of PTH(1-34) on carbachol-evoked Ca
2+
 signals 152 
require neither PKA nor EPACs (Tovey et al., 2008). The latter conclusion came from 153 
experiments in which a membrane-permeant analogue of cAMP that selectively activates 154 
EPACs (8-Br-2'-O-Me-cAMP) did not mimic the effects of PTH(1-34) or 8-Br-cAMP on 155 
carbachol-evoked Ca
2+
 signals. That conclusion is strengthened by results with a new 156 
membrane-permeant antagonist of EPAC1/2 (ESI-09) (Almahariq et al., 2013). ESI-09 (10 157 
µM, 5 min) had no significant effect on the Ca
2+
 signals evoked by carbachol alone, the 158 
concentration-dependent potentiation by PTH(1-34) on carbachol-evoked Ca
2+
 signals, or the 159 
small Ca
2+ 
signals directly evoked by high concentrations of PTH(1-34) (supplementary 160 
material Figs. S1E, S2A,B). It was impracticable to use higher concentrations of ESI-09 or 161 
more prolonged treatments because they directly inhibited carbachol-evoked Ca
2+
 release 162 
(supplementary material Fig. S2A,C). Others have also recently reported non-specific effects 163 
of ESI-09 (Rehmann, 2013). A competitive antagonist of EPACs like ESI-09 might be 164 
ineffective if high concentrations of cAMP are locally delivered to IP3Rs from AC (Tovey et 165 
al., 2008). However, potentiation of carbachol-evoked Ca
2+
 signals by 8-Br-cAMP, which is 166 
uniformly distributed in the cytosol, was also unaffected by ESI-09 (supplementary material 167 
Fig. S2D).  168 
 These results confirm that EPACs and PKA are not involved in the potentiation of 169 
carbachol-evoked Ca
2+
 signals by PTH(1-34) or the direct effects of high concentrations of 170 
PTH(1-34) on Ca
2+
 signals. The latter, with evidence that some analogues of PTH stimulate 171 
AC without directly evoking Ca
2+
 signals (Fig. 1D,F), suggest that cAMP/EPAC-mediated 172 
activation of PLCε (Schmidt et al., 2001) does not contribute to PTH-evoked Ca2+ signals in 173 
HEK-PR1 cells. We conclude, and consistent with previous work (Tovey et al., 2008), that in 174 
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HEK-PR1 cells the effects of PTH(1-34) on carbachol-evoked Ca
2+
 release are mediated by 175 
cAMP, which sensitizes IP3Rs to IP3 without need for activation of PKA or EPACs (Fig. 1A). 176 
 177 
Sustained stimulation with PTH reduces potentiation of carbachol-evoked Ca
2+
 signals 178 
PTH(1-34) stimulates delivery of cAMP to IP3Rs within signalling junctions (Tovey et al., 179 
2008; Tovey and Taylor, 2013). This, together with evidence that stimulation of AC at the 180 
plasma membrane is followed by internalization of functional PTH1R∙AC signalling 181 
complexes (see Introduction), prompted us to examine responses of HEK-PR1 cells to 182 
carbachol after sustained stimulation with PTH(1-34). 183 
 Varying the duration of the incubation with PTH(1-34) before addition of carbachol 184 
established that sustained exposure to PTH(1-34) reduced the maximal amplitude of the 185 
carbachol-evoked Ca
2+
 signals by ~50%, while increasing the sensitivity to PTH(1-34) by 186 
almost 10-fold (Fig. 2A,B, supplementary material Table S2). These effects were apparent 187 
after 15-30 min, and not further increased by extending the incubation with PTH(1-34) to 60 188 
min. The inhibition (~50%) was similar whether maximal or submaximal carbachol 189 
concentrations were used to evoke the Ca
2+
 signals. Analyses of single cells showed that the 190 
reduced maximal response after prolonged incubation with PTH(1-34) was due to diminished 191 
Ca
2+
 signals within individual cells rather than to fewer cells responding (Fig. 2C,D). The 192 
diminished amplitude of the potentiated Ca
2+
 signals was not due to loss of Ca
2+
 from 193 
intracellular stores. Neither Tyr
1
PTH(1-34) nor PTH(2-38) directly stimulated Ca
2+
 release 194 
from intracellular stores (Fig. 1F), but responses to carbachol after brief and sustained 195 
stimulation with these analogues were similar to those evoked by equivalent treatments with 196 
PTH(1-34) (supplementary material Table S3). Furthermore, addition of ionomycin to cells in 197 
Ca
2+
-free HBS to assess the Ca
2+ 
contents of the stores after incubation with PTH(1-34) 198 
showed that the increase in [Ca
2+
]c evoked by ionomycin was unaffected by acute or 199 
sustained stimulation with PTH(1-34) (Fig. 2E,F). The indistinguishable responses were not 200 
due to saturation of the Ca
2+
 indicator because restoration of extracellular Ca
2+
 after 201 
ionomycin evoked a much larger increase in fluo 4 fluorescence (Fig. 2E). Using similar 202 
methods to measure the residual Ca
2+
 content of the stores after stimulation with PTH(1-34) 203 
and carbachol, showed that more Ca
2+
 remained within the stores of cells stimulated with 204 
carbachol after prolonged treatment with PTH(1-34) (peak increase in [Ca
2+
]c = 181 ± 12 nM) 205 
than after brief treatment (97 ± 4 nM, P < 0.05) (Fig. 2F). This again indicates that 206 
diminished responses after sustained treatment with PTH(1-34) are not due to loss of Ca
2+
 207 
from intracellular stores. We conclude that sustained stimulation with PTH(1-34) reduces the 208 
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maximal potentiation of carbachol-evoked Ca
2+
 signals without affecting the Ca
2+
 content of 209 
the stores. 210 
 211 
Sustained stimulation with PTH reduces intracellular concentrations of IP3 212 
The effects of acute and sustained stimulation with PTH(1-34) on the changes in cytosolic IP3 213 
concentration evoked by a submaximal concentration of carbachol (30 μM) were measured in 214 
single HEK-PR1 cells using a FRET-based IP3 sensor. Cells were first stimulated with 1 mM 215 
carbachol (3 min, S1) to identify responsive cells (Fig. 3A). After washing and a 30-min 216 
recovery interval, cells were then stimulated with 30 μM carbachol (3 min, S2). The dual-217 
stimulation protocol, with PTH(1-34) (100 nM) added 1 or 30 min before the second 218 
carbachol stimulus, allowed paired single-cell comparisons of treatments (S2/S1). This 219 
analysis reduced the variability arising from the limited dynamic range of the sensor. The 220 
control response shows that the FRET signal evoked by 30 μM carbachol was less than that 221 
with 1 mM carbachol (Fig. 3A), and it was unaffected by prior exposure to 1 mM carbachol 222 
(Fig. 3B). These results confirm that  the sensor was not saturated by the experimental 223 
stimulus. Addition of PTH(1-34) 1 min before the second challenge had no effect on the 224 
response to carbachol (Fig. 3C,E). This is consistent with evidence that acute stimulation with 225 
PTH(1-34) does not stimulate PLC in HEK-PR1 cells (Tovey et al., 2008; Tovey and Taylor, 226 
2013). However, a 30-min pretreatment with PTH(1-34) significantly reduced the increase in 227 
cytosolic IP3 evoked by carbachol (Fig. 3D,F,G). We conclude that sustained stimulation with 228 
PTH(1-34) reduces the stimulatory effect of carbachol on the cytosolic levels of IP3. 229 
 230 
Internalization of AC signalling pathways does not mediate sustained effects of PTH on 231 
carbachol-evoked Ca
2+
 signals 232 
We used PTH analogues that differ in their abilities to evoke internalization of PTH1R to 233 
assess whether endocytosis of functional AC-signalling pathways contributes to the sustained 234 
effects of PTH(1-34) on carbachol-evoked Ca
2+
 signals. PTH(1-34) evokes receptor 235 
internalization and sustained signalling from endosomal AC, PTH(2-38) does not evoke 236 
receptor internalization, Tyr
1
PTH(1-34) is a weak partial agonist for receptor internalization, 237 
and PTHrP(1-36) evokes receptor internalization but no persistent AC signalling (see 238 
supplementary material Table S1). The acute and sustained effects of each analogue on 239 
carbachol-evoked Ca
2+
 signals were similar to those evoked by PTH(1-34) (Fig. 4A-D, 240 
supplementary material Table S3). For each PTH analogue, the maximal amplitude of the 241 
Ca
2+
 signal evoked by carbachol was smaller after sustained stimulation, despite each causing 242 
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intracellular levels of cAMP to be greater after stimulation for 30 min relative to 1 min (Fig. 243 
4E-H, supplementary material Table S3). Although PTHrP(1-36) mimicked the effects of 244 
PTH(1-34) in potentiating carbachol-evoked Ca
2+ 
signals, it stimulated lesser cAMP 245 
accumulation. This is unexpected because others suggest that PTHrP(1-36) (Dean et al., 246 
2008), PTHrP(1-34) and PTHrP(1-37) (Cupp et al., 2013) are as efficacious as PTH(1-34) in 247 
stimulating accumulation of cAMP, albeit in cells with 10-fold greater levels of PTH1R 248 
expression (Dean et al., 2008). We have not further explored this issue. For most PTH 249 
analogues, the sensitivity to PTH of both cAMP accumulation and Ca
2+
 signalling increased 250 
during sustained stimulation (ΔpEC50 values in supplementary material Table S3). This 251 
suggests that a component of the increased sensitivity of the Ca
2+
 signals is probably due to 252 
the increased sensitivity of AC activation to PTH during prolonged stimulation. The more 253 
important point for the present work is that for all the PTH analogues, sustained stimulation 254 
causes greater accumulation of cAMP, but lesser potentiation of carbachol-evoked Ca
2+
 255 
signals. Collectively, these results suggest that internalization of functional PTH1R signalling 256 
complexes is unlikely to be responsible for the sustained effects of PTH on carbachol-evoked 257 
Ca
2+
 signals. We therefore assessed the effects of more directly evoking sustained elevations 258 
in intracellular cAMP concentration on carbachol-evoked Ca
2+
 signals. 259 
 Brief stimulation (1-5 min) with 8-Br-cAMP, PTH(1-34) or NKH477, a soluble analogue 260 
of forskolin that directly activates AC (Ito et al., 1993), caused similar potentiation of 261 
carbachol-evoked Ca
2+
 signals (Fig. 5A-C) and their maximal effects were non-additive (Fig. 262 
5D). Because the three stimuli take different times to reach their targets, incubation periods 263 
(1-5 min) were optimized for each to achieve maximal potentiation of carbachol-evoked Ca
2+
 264 
signals. The results extend previous work (Tovey et al., 2008) by confirming that cAMP 265 
alone mediates potentiation of carbachol-evoked Ca
2+
 signals by PTH(1-34). However, the 266 
relationship between intracellular cAMP and Δ[Ca2+]c is different for PTH(1-34), PTHrP(1-267 
36) and NKH477 (Fig. 5E): the effects of PTH(1-34) on Ca
2+
 signals are associated with 268 
much larger accumulations of cAMP than are comparably potentiated Ca
2+
 signals evoked by 269 
PTHrP(1-36) or NKH477. This indicates that IP3R cannot be responding to a uniformly 270 
delivered global increase in cytosolic cAMP. 271 
 Sustained exposure to PTH(1-34), NKH477 or 8-Br-cAMP caused similar decreases in the 272 
maximal potentiation of carbachol-evoked Ca
2+
 signals, and again the maximal effects of 273 
each were non-additive (Fig. 5A-D, supplementary material Table S4 and S5). For both 274 
PTH(1-34) and NKH477, prolonged stimulation reduced the apparent effectiveness of cAMP 275 
in potentiating carbachol-evoked Ca
2+
 signals (Fig. 5F and G). Neither the acute nor 276 
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sustained effects of PTH(1-34), NKH477 or 8-Br-cAMP were affected by inhibition of PKA, 277 
because treatment with H89 had no effect, under conditions where H89 inhibits PKA-278 
mediated phosphorylation of proteins, (Tovey et al., 2008) (Fig. 6 and supplementary 279 
material Fig. S3A). There was also no effect of H89 on the amount of cAMP produced after 280 
stimulation with PTH(1-34) for 1 or 60 min. For cells treated with H89, amounts of 281 
intracellular cAMP detected after stimulation with 3 μM PTH(1-34) for 1 or 60 min were 95 282 
± 0.1 and 98 ± 0.2% of those detected in matched control cells (n = 3) (Supplementary 283 
material Fig. S3B) . We conclude that sustained elevations of intracellular cAMP, whether 284 
evoked by activation of PTH1R or directly, attenuate the potentiation of carbachol-evoked 285 
Ca
2+
 signals. Neither the potentiation of Ca
2+
 signals by cAMP nor the diminished response 286 
after sustained elevation of cAMP requires activation of PKA. 287 
 288 
Brief and sustained stimulation with PTH potentiate carbachol-evoked Ca
2+
 signals via 289 
cAMP junctions 290 
Although cAMP mediates the effects of PTH on carbachol-evoked Ca
2+
 signals (Tovey et al., 291 
2008), sustained exposure to PTH causes a more substantial increase in intracellular cAMP 292 
than acute stimulation, but a lesser potentiation of carbachol-evoked Ca
2+
 signals (Fig. 4, 293 
supplementary material Table S3). The reduced effectiveness of cAMP with increased 294 
duration of exposure is clear from comparison of the relationships between cAMP and 295 
potentiated Ca
2+
 signals for cells stimulated acutely or chronically with PTH(1-34) or 296 
NKH477 (Fig. 5F,G).  297 
 Acute (1 min) potentiation of carbachol-evoked Ca
2+
 signals by PTH(1-34) was unaffected 298 
by substantially inhibiting cAMP formation (by inhibiting AC with SQ/DDA) or degradation 299 
(by inhibiting cyclic nucleotide phosphodiesterases with IBMX), although both treatments 300 
had the expected effects on intracellular cAMP (Fig. 7A,B supplementary material Table S6, 301 
Fig. S3C,D). Figure S3E demonstrates that if the cAMP that regulates IP3R were uniformly 302 
distributed, the observed 60-70% inhibition of AC by SQ/DDA would cause a detectable 303 
inhibition of the effects of PTH(1-34) on carbachol-evoked Ca
2+
 signals. The lack of effect of 304 
SQ/DDA on Ca
2+
 responses is not, therefore, a limitation of our methods. Similar results 305 
were obtained when NKH477 was used to acutely stimulate AC. SQ/DDA and IBMX had the 306 
expected effects on intracellular concentrations of cAMP (Fig. 7C,D), but they had no effect 307 
on the potentiation of carbachol-evoked Ca
2+ 
signals (Fig. 7E,F). These results confirm 308 
previous work, where we argued that the inability of SQ/DDA or IBMX to affect potentiation 309 
of carbachol-evoked Ca
2+
 signals by any concentration of acutely presented PTH(1-34), 310 
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despite substantial effects on intracellular concentrations of cAMP, suggests that cAMP is 311 
locally delivered at super-saturating concentrations to IP3R (Tovey et al., 2008; Tovey and 312 
Taylor, 2013). We propose that the concentration-dependent effects of PTH(1-34) then arise 313 
from recruitment of these signalling junctions, rather than from graded activity within each 314 
(Fig. 7G). 315 
 In cells stimulated with PTH(1-34) for 60 min, cAMP formation was reduced by ~70% 316 
after inhibition of AC by SQ/DDA, but there was no significant effect on the potentiation of 317 
carbachol-evoked Ca
2+
 signals (supplementary material Table S6). Similar effects were 318 
observed after sustained stimulation with NKH477: cAMP accumulation was substantially 319 
inhibited by SQ/DDA without affecting the concentration-dependent effects of NKH477 on 320 
carbachol-evoked Ca
2+
 signals (Fig. 8A,B). These results suggest that the sustained effects of 321 
PTH or direct activation of AC on carbachol-evoked Ca
2+
 signals are, like those evoked by 322 
acute stimulation, mediated by hyperactive cAMP junctions. 323 
 IBMX massively increased the amount of cAMP produced after sustained stimulation with 324 
PTH(1-34) or NKH477. In parallel analyses, IBMX significantly increased the sensitivity of 325 
carbachol-evoked Ca
2+
 signals to PTH(1-34) and NKH477 without affecting the maximal 326 
amplitude of the increase in [Ca
2+
]c (Fig. 8A,C-F, supplementary material Table S6). The 327 
latter remained smaller than the increase observed after acute stimulation, demonstrating that 328 
even massive increases in intracellular cAMP concentration cannot surmount the attenuation 329 
of potentiated Ca
2+ 
signals after sustained stimulation with PTH. As with all other analyses, 330 
inhibition of PKA (with H89) had no effect on the potentiation of carbachol-evoked Ca
2+
 331 
signals by PTH(1-34) in the presence of IBMX (supplementary material Fig. S4), re-332 
affirming that PKA is not involved in the potentiation of carbachol-evoked Ca
2+
 signals.  333 
 Whereas SQ/DDA had no effect on the acute potentiation of Ca
2+
 signals by PTH(1-34) 334 
alone or with IBMX (Fig. 7, supplementary material Fig. S3), it partially reversed the 335 
increase in sensitivity to PTH(1-34) during sustained stimulation with PTH(1-34) and IBMX 336 
(Fig. 8E). These opposing effects of IBMX and SQ/DDA on the sensitivity of carbachol-337 
evoked Ca
2+
 signals to PTH(1-34) confirm the role of cAMP in mediating the effect. 338 
Sustained stimulation (60 min) with PTH(1-34) in the presence of IBMX generated levels of 339 
intracellular cAMP that were 22-fold greater than those evoked by acute (1 min) stimulation 340 
(supplementary material Table S6). Although SQ/DDA substantially inhibited AC, the 341 
amount of intracellular cAMP in cells stimulated with PTH(1-34) for 60 min with IBMX 342 
remained substantially greater than during acute stimulation (Fig. 8F, supplementary material 343 
Table S6). These results suggest that when the global intracellular cAMP concentration is 344 
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massively increased, it achieves levels that can sensitize the Ca
2+
 signals evoked by carbachol 345 
without need for cAMP signalling junctions. Under these conditions, cAMP will sensitize 346 
both junctional IP3R and extra-junctional IP3R. Recruitment of the latter would be expected 347 
to be attenuated by inhibition of AC, while junctional signalling would be unaffected (Fig. 348 
8G).  349 
 350 
Discussion 351 
Signalling from PTH1R to Ca
2+
 signals via AC-IP3R junctions 352 
PTH(1-34) potentiates carbachol-evoked Ca
2+
 release by increasing the sensitivity of IP3R 353 
(Fig. 1A). The potentiated response is mediated by cAMP, it requires neither protein kinase A 354 
nor EPACs, and probably results from cAMP binding directly to IP3R or closely associated 355 
proteins (Tovey et al., 2010; Tovey et al., 2008). Despite cAMP being the essential link 356 
between PTH1R and Ca
2+
 signalling, acute responses to all concentrations of PTH(1-34) or to 357 
direct stimulation of AC (with NKH477) were insensitive to inhibition of either AC (with 358 
SQ/DDA) or cyclic nucleotide phosphodiesterases (with IBMX), although each inhibitor had 359 
the expected effect on global concentrations of intracellular cAMP (Fig. 7, supplementary 360 
material Table S6, Fig. S3). This, together with the inconsistent relationship between 361 
intracellular cAMP and Ca
2+
 signals for different analogues of PTH and direct stimulation of 362 
AC (Fig. 5E), establish that the responses are not mediated by global cAMP signals 363 
uniformly delivered to the cytosol. Instead, we suggest that cAMP is delivered to IP3R within 364 
signalling junctions at concentrations more than sufficient to fully sensitize associated IP3R. 365 
We propose that the concentration-dependent effects of PTH(1-34) then result from 366 
recruitment of these digital junctions, rather than from graded activity within individual 367 
junctions (Fig. 7G) (Tovey et al., 2008). This evidence that potentiation of carbachol-evoked 368 
Ca
2+
 signals by PTH(1-34) requires local communication between AC and IP3R motivated 369 
our analysis of sustained responses to PTH(1-34) during which functional AC signalling 370 
pathways are internalized (see Introduction). 371 
 372 
Sustained signalling from PTH1R via AC-IP3R junctions 373 
Sustained stimulation with PTH(1-34) potentiated carbachol-evoked Ca
2+
 signals, but the 374 
maximal amplitude of the response was smaller than with acute stimulation, and the 375 
sensitivity to PTH(1-34) was increased (Figs. 2A,B and 4). The latter may, at least in part, be 376 
due to an increase in the sensitivity of cAMP accumulation to PTH(1-34) during sustained 377 
stimulation (supplementary material Table S3). The diminished Ca
2+
 responses were not due 378 
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to fewer cells responding or to loss of Ca
2+
 from intracellular stores (Fig. 2), and they were 379 
unaffected by inhibition of PKA (Fig. 6). Acute and sustained Ca
2+
 responses to PTH 380 
analogues that differ in whether they evoke internalization of functional AC signalling 381 
complexes were similar to those evoked by PTH(1-34) (Fig. 4). Furthermore, acute and 382 
sustained responses to 8-Br-cAMP or direct activation of AC mimicked the responses evoked 383 
by PTH(1-34), and the maximal effects of sustained exposure to each stimulus were non-384 
additive (Fig. 5A-D). Collectively, these results suggest that additional effects of active 385 
PTH1R, like stimulation of phosphatidylinositol 3-kinase and Akt (Yamamoto et al., 2007), 386 
are unlikely to contribute to the sustained effects of PTH on CCh-evoked Ca
2+
 signals. 387 
Instead, we conclude that attenuated potentiation of carbachol-evoked Ca
2+
 signals during 388 
sustained exposure to PTH(1-34) is mediated by a sustained increase in cytosolic cAMP that 389 
does not require PKA or internalization of PTH1R signalling complexes. 390 
 The insensitivity of the sustained responses to PTH(1-34) and NKH477 to substantial 391 
inhibition of AC (Fig. 8) suggests that hyperactive cAMP signalling junctions regulate the 392 
changes in signalling to IP3R that occur during sustained activation of AC. We conclude, and 393 
despite evidence that sustained stimulation with PTH(1-34) evokes internalization of 394 
functional AC signalling complexes (Ferrandon et al., 2009), that PTH1R retains its ability to 395 
signal via hyperactive AC-IP3R signalling junctions during sustained stimulation. Sustained 396 
stimulation with PTH(1-34) in the presence of IBMX caused the global concentration of 397 
intracellular cAMP to increase to levels sufficient to sensitize IP3R without the usual need for 398 
junctional delivery of cAMP. This was evident from the increased sensitivity to PTH(1-34) 399 
and NKH477 after sustained stimulation in the presence of IBMX, and its partial reversal by 400 
inhibition of AC with SQ/DDA (Fig. 8). Our demonstration that SQ/DDA can, under these 401 
experimental conditions, attenuate the effects of PTH(1-34) on carbachol-evoked Ca
2+
 signals 402 
reinforces our conclusion that hyperactive cAMP signalling junctions normally mediate the 403 
effects of PTH(1-34). Although the global increase in cAMP increased the sensitivity to 404 
PTH(1-34) and NKH477, it had no effect on the maximal response, which remained smaller 405 
than that evoked by acute stimulation. This demonstrates that ineffective delivery of cAMP to 406 
IP3R during sustained stimulation does not cause the diminished potentiation of carbachol-407 
evoked Ca
2+
 signals. Instead, sustained increases in intracellular cAMP reduce the 408 
accumulation of cytosolic IP3 after carbachol stimulation (Fig. 3). We have not addressed 409 
whether this results from decreased production or enhanced degradation of IP3. However, the 410 
diminished responses to carbachol during sustained stimulation with PTH((1-34) are 411 
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mediated by cAMP (Figs. 5-8), independent of PKA (Fig. 6), and dependent on delivery of 412 
cAMP within hyperactive signalling junctions (Fig. 8).  413 
 We conclude that PTH(1-34) via PTH1R stimulates AC and locally delivers cAMP at 414 
supersaturating concentrations to associated IP3R, thereby increasing their sensitivity to IP3 415 
and so potentiating the Ca
2+
 signals evoked by carbachol (Fig. 8G). This junctional delivery 416 
of cAMP is maintained during sustained stimulation with PTH(1-34), but prolonged activity 417 
of the junctions leads to an inhibition of IP3 accumulation. These cAMP junctions which 418 
behave as ‘on-off’, or digital, switches, allow fast and robust signalling from AC to its 419 
targets. The cAMP then mediates both the initial effects of PTH(1-34) on Ca
2+
 signals and the 420 
longer term attenuation of the response without need for activation of PKA. 421 
 422 
Materials and Methods 423 
Materials  424 
N-[2-[[3-(4-bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide 425 
dihydrochloride (H89) and 8-Br-cAMP were from R&D Systems (Minneapolis, MN, USA). 426 
2',5'-dideoxyadenosine (DDA), N,N-dimethyl-(3R,4aR,5S,6aS,10S,10aR,10bS)-5-(acetyloxy)-427 
3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho[2,1-428 
b]pyran-6-yl ester β-alanine hydrochloride (NKH477) and 9-(tetrahydro-2-furanyl)-9H-purin-429 
6-amine (SQ22536) were from Merck Biosciences (Middlesex, UK). [2,8-
3
H]-adenine was 430 
from Perkin Elmer (Waltham, MA, USA). 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-431 
tetraacetic acid (BAPTA) was from Molekula (Gillingham, UK). Carbamylcholine chloride 432 
(carbachol, CCh) and 3-isobutyl-1-methylxanthine (IBMX) were from Sigma-Aldrich 433 
(Gillingham, UK). Ionomycin was from Apollo Scientific (Stockport, UK). Cell culture 434 
media, G-418, fluo 4AM and fura 2AM were from Life Technologies (Paisley, UK). 3-[5-435 
(tert-butyl)isoxazol-3-yl]-2-[2-(3-chlorophenyl)hydrazono]-3-oxopropanenitril (ESI-09) was 436 
from Biolog Life Science Institute (Bremen, Germany). All PTH analogues were human 437 
forms and supplied by either Bachem (Bubendorf, Switzerland) or, for PTHrP(1-36), custom-438 
synthesized by Selleckchem (Boston, MA, USA). Sequences of the analogues used are listed 439 
in supplementary material Table S1. 440 
 441 
Measurements of [Ca
2+
]c 442 
HEK-PR1 cells (~10
5
 PTH1R/cell) were cultured as described (Tovey et al., 2008). 443 
Measurements of [Ca
2+
]c in cell populations were performed as previously described (Tovey 444 
et al., 2008). Briefly, confluent cultures of HEK-PR1 grown in 96-well plates were loaded 445 
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with fluo 4 by incubation with fluo 4AM (2 µM, 20
o
C) in HEPES-buffered saline (HBS). 446 
HBS had the following composition (mM): NaCl 135, KCl 5.9, MgCl2 1.2, CaCl2 1.5, 447 
HEPES 11.6 and glucose 11.5, pH 7.3. After 1 h, loading medium was replaced with HBS, 448 
and after 45 min cells were used at 20
o
C for measurements of [Ca
2+
]c. A fluorescence plate-449 
reader equipped to allow automated fluid additions (FlexStation 3, Molecular Devices, 450 
Sunnyvale, CA, USA) was used to record fluorescence at intervals of 1.44 s (excitation at 485 451 
nm; emission at >525 nm) (Tovey et al., 2006). Fluorescence (F) was calibrated to [Ca
2+
]c 452 
from: [Ca
2+
]c = KD(F-Fmin)/(Fmax-F), where KD is the equilibrium dissociation constant of fluo 453 
4 for Ca
2+
 (345 nM); Fmin and Fmax were measured from cells treated with Triton X-100 (0.2 454 
%, v/v) in the presence of BAPTA (10 mM) or CaCl2 (10 mM).  455 
 For single-cell measurements of [Ca
2+
]c, near-confluent cultures of HEK-PR1 cells were 456 
grown on poly-L-lysine-coated round coverslips (22-mm diameter) and loaded with fura 2 by 457 
incubation with fura 2AM (2 µM, 45 min, 20°C) in HBS. The medium was removed and 458 
cells were incubated for a further 45 min in HBS at 20
o
C before single-cell imaging using an 459 
Olympus IX71 inverted fluorescence microscope. Cells were alternately excited at 5-s 460 
intervals with light (340 nm and 380 nm) from a Xe-arc lamp and monochromator, while 461 
collecting emitted light at 510 nm using a Luca EMCCD camera (Andor Technology, Belfast, 462 
UK) and MetaFluor software (Molecular Devices, Sunnyvale, CA). Autofluorescence was 463 
determined at the end of each experiment by addition of ionomycin (1 µM) and MnCl2 (10 464 
mM) and subtracted from measurements before computing fluorescence ratios (R = 465 
F340/F380). These were calibrated to [Ca
2+
]c from:   466 
           
       
      
  
  
  
 
where the KD for fura 2 is 224 nM, Rb and Rf are the fluorescence ratios for fura 2 with and 467 
without Ca
2+
 bound, and Fb and Ff are the fluorescence recorded at 380 nM with and without 468 
Ca
2+
.  469 
 Concentration-effect relationships were fitted to Hill equations using Prism version 5 470 
(GraphPad, San Diego, CA, USA). Results are shown as means ± s.e.m.. Statistical 471 
comparisons of sensitivities used pEC50 values (-log of the half-maximally effective 472 
concentration, EC50). Because our experiments were performed over a prolonged period 473 
using HEK-PR1 cells from different passages, there is some variability in the absolute 474 
sensitivities to carbachol and PTH(1-34), and in the amplitudes of the Ca
2+
 signals evoked. 475 
All statistical comparisons are therefore between experiments performed in parallel and 476 
analysed using paired Student's t-tests. 477 
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 478 
Measurements of intracellular cAMP 479 
These assays were performed under conditions that replicate those used for measurements of 480 
[Ca
2+
]c. HEK-PR1 cells were grown in 24-well plates until ~90% confluent, 
3
H-adenine (2 481 
µCi.well
-1
) was then added to the culture medium. After 2 h at 37
o
C in 5% CO2, the medium 482 
was removed, cells were washed with HBS, and used for experiments in HBS at 20
o
C. 483 
Because many cells extrude cAMP into the extracellular medium (Copsel et al., 2011), 484 
reactions were terminated by first removing the medium and then adding ice-cold 485 
trichloroacetic acid (5% v/v, 1 mL). After 30 min on ice, 
3
H-cAMP was separated from other 486 
3
H-adenine nucleotides by sequential column chromatography on Dowex cation exchange 487 
resin and alumina as previously described (Pantazaka et al., 2013). The activity of the eluates 488 
was determined by liquid scintillation counting and amounts of 
3
H-cAMP are expressed as 489 
percentages of the sum of the activities recovered in the 
3
H-cAMP, 
3
H-ADP and 
3
H-ATP 490 
fractions. 491 
   492 
Measurements of intracellular IP3  493 
A Fӧrster resonance energy transfer (FRET) sensor based on the IP3-binding core of IP3R1 494 
(Tovey and Taylor, 2013) was used to measure cytosolic concentrations of IP3 in single 495 
HEK-PR1 cells under conditions similar to those used for measurements of [Ca
2+
]c. The 496 
plasmid and properties of the sensor were described previously (Tovey and Taylor, 2013). 497 
The sensor comprises the IP3-binding core attached via short linkers to enhanced cyan 498 
fluorescent protein (CFP) at its N terminal and enhanced yellow fluorescent protein (YFP) at 499 
its C-terminal (see inset to Fig. 3A). IP3 binding causes a decrease in FRET. HEK-PR1 cells 500 
on poly-L-lysine-coated, 22-mm diameter, glass coverslips were grown for 48 h in 6-well 501 
plates to ~60% confluence. Cells were then transiently transfected with plasmid encoding the 502 
IP3-sensor (1 μg) using Lipofectamine LTX reagent with PLUS reagent, according to the 503 
manufacturer's instructions (Life Technologies, Paisley, UK). Cells were imaged after 48 h. 504 
An Olympus IX71 inverted fluorescence microscope with a 40x objective and a 440 nm/520 505 
nm dual band-pass dichroic mirror was used to record fluorescence from widefield images 506 
after excitation at 440 nm (to excite CFP). A Luca EMCCD camera (Andor Technology, 507 
Belfast, UK) was used to collect emitted fluorescence simultaneously at 1-s intervals from 508 
YFP (520–550 nm) and CFP (455–485 nm) using a Cairn Optosplit 2 image-splitter fitted 509 
with  a 495-nm dichroic mirror. After correction for background fluorescence (determined 510 
from cytosolic areas of non-transfected cells), FRET ratios are presented as CFP 511 
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emission/YFP emission, so that the ratio increases (decreased FRET) after IP3 binding. The 512 
transfection efficiency was ~65%, and 52 ± 2% (n = 17 coverslips) of transfected cells 513 
responded to carbachol (1 mM) with discernible FRET changes; only these responsive cells 514 
were included in analyses of the effects of PTH(1-34). 515 
 516 
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Fig. 1. Potentiation of carbachol-evoked Ca
2+
 signals by PTH(1-34) is mediated by 623 
cAMP. (A) Local delivery of cAMP to IP3R within ‘signalling junctions’ (red box) allows 624 
stimulation of PTH1R to increase the sensitivity of IP3R to IP3. This potentiates the Ca
2+
 625 
release evoked by IP3 produced in response to activation of M3 muscarinic acetylcholine 626 
receptors (M3R). All-or-nothing activation of these signalling junctions is analogous to the 627 
behaviour of focally innervated skeletal muscle (lower panel), where release of acetylcholine 628 
at the neuromuscular junction (red box) evokes all-or-nothing contraction of individual 629 
myofibrils. Graded contraction of the muscle fibre then results from recruitment of 630 
contracting myofibrils (right panels). See text for further explanation. (B) Typical changes in 631 
[Ca
2+
]c from a population of HEK-PR1 cells stimulated with a submaximal concentration of 632 
carbachol (CCh, 20 μM) alone (black) or with PTH(1-34) (100 nM, added 1 min before 633 
carbachol, red). BAPTA (2.5 mM) was added before carbachol to chelate extracellular Ca
2+
. 634 
Results are means ± s.d. from 2 wells in a single experiment. (C) Summary results show 635 
concentration-dependent effects of PTH analogues added 1 min before 20 μM carbachol. (D) 636 
Effects of PTH analogues on intracellular cAMP measured after 1 min under conditions 637 
identical to those used for measurements of [Ca
2+
]c. Results show 
3
H-cAMP as a percentage 638 
of 
3
H-ATP, 
3
H-ADP and 
3
H-cAMP. Results (C-E) are means ± s.e.m. from at least 3 639 
experiments. (E) Results from C and D were used to establish the relationship between 640 
cAMP and the potentiated carbachol-evoked increases in [Ca
2+
]c for cells stimulated with the 641 
indicated PTH analogues for 1 min. (F) Concentration-dependent effects of PTH analogues 642 
alone on the peak increases in [Ca
2+
]c. The reported abilities of the analogues to stimulate 643 
PLC and/or AC are shown.  644 
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Fig. 2. Sustained stimulation with PTH(1-34) reduces potentiated carbachol-evoked 645 
Ca
2+
 signals without affecting the Ca
2+ 
content of the intracellular stores. (A, B) 646 
Populations of HEK-PR1 cells were incubated with the indicated concentrations of PTH(1-647 
34) for 1-60 min in HBS before addition of BAPTA (2.5 mM) and either 20 μM (A) or 1 mM 648 
carbachol (CCh) (B). The code applies to both panels. Results (A and B) show means ± 649 
s.e.m., n = 4. (C, D) Single-cell analyses show the percentage of cells in which carbachol (1 650 
mM) evoked a detectable increase in [Ca
2+
]c in control cells or after stimulation with PTH(1-651 
34) (100 nM) for 1 or 60 min (C), and the increase in [Ca
2+
]c evoked by carbachol under each 652 
condition (D). In these experiments, normal HBS was replaced by nominally Ca
2+
-free HBS 653 
5 min before addition of carbachol. Results (C and D) are from 3 coverslips each with ~65 654 
cells. (E) Effect of prolonged stimulation with PTH(1-34) on the Ca
2+
 contents of the 655 
intracellular stores was assessed by incubating populations of cells with PTH(1-34) for 30 656 
min, before addition of BAPTA (2.5 mM) and then ionomycin (1 μM). Restoration of 657 
extracellular Ca
2+
 (10 mM) at the end of the experiment confirmed that the indicator was not 658 
saturated by the Ca
2+ 
signals evoked by ionomycin. Results show a typical trace from 5 wells 659 
in 1 experiment. RFU, relative fluorescence units. (F) Similar experiments show the effects 660 
of treatment for 1 or 30 min with PTH(1-34) (100 nM) on the peak Ca
2+
 signals evoked in 661 
Ca
2+
-free HBS by carbachol (20 µM, open bars) or ionomycin (1 μM, solid bars). Results are 662 
means ± s.e.m., n = 3.  663 
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Fig. 3. Sustained stimulation with PTH(1-34) reduces carbachol-evoked increases in 664 
cytosolic IP3 concentration. (A) Cytosolic IP3 was measured in single HEK-PR1 cells using 665 
a fluorescence resonance energy transfer (FRET) sensor during stimulation (3 min) with 1 666 
mM carbachol (CCh) (S1) and then, after washing, with 30 μM carbachol added 30 min later 667 
(S2). The trace shows typical results from a cell with no intervening PTH treatment. FRET is 668 
shown as CFP/YFP fluorescence, so that an increased signal (decreased FRET) corresponds 669 
to an increase in IP3 concentration (see Methods). The inset shows the IP3 sensor with 670 
excitation and emission (italics) wavelengths in nm. IBC, IP3-binding core. (B) Summary 671 
results (means ± s.e.m. for 62 cells from 6 coverslips) show ΔFRET (stimulated / basal 672 
signal) for cells stimulated with the indicated carbachol concentrations presented as either the 673 
first (S1) or second stimulus (S2, i.e. after 1 mM carbachol). (C, D) Typical results from 674 
single cells subject to similar treatments, but with PTH(1-34) (100 nM) added 1 min (C) or 675 
30 min (D) before, and then during, the second addition of carbachol. (E, F) Summary results 676 
show ΔFRET for the first and second carbachol stimulation (S1 and S2) as means ± s.e.m. for 677 
36 and 34 cells from 5 (E) and 7 (F) coverslips. (G) For each cell, ΔFRET measurements for 678 
the first (S1, 1 mM carbachol) and second stimulus (S2, 30 μM carbachol) were used to 679 
calculate S2/S1 for the indicated treatments. Results are means ± s.e.m. for 28-36 cells. 680 
 681 
Fig. 4. Internalization of adenylyl cyclase signalling pathways does not contribute to 682 
diminished potentiation of Ca
2+
 signals after sustained stimulation with PTH. (A-D) 683 
Cells were stimulated for 1 or 30 min with PTH analogues before addition of carbachol (20 684 
μM) in Ca2+-free HBS. The peak increases in [Ca2+]c evoked by carbachol are shown. (E-H) 685 
Parallel measurements of intracellular cAMP measured under identical conditions. Results 686 
are means ± s.e.m., from at least 3 experiments. The code shown in panel A applies to all 687 
panels.  688 
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Fig. 5. Diminished potentiation of carbachol-evoked Ca
2+
 signals after sustained 689 
increases in intracellular cAMP concentration. (A-C) Peak increases in [Ca
2+
]c evoked by 690 
addition of carbachol (20 μM) in Ca2+-free HBS to cells preincubated with PTH(1-34) (A), 691 
NKH477 (B), or 8-Br-cAMP (C) for the indicated times. Δ[Ca2+]c denotes the difference in 692 
the peak increase in [Ca
2+
]c evoked by carbachol alone and after each pretreatment. (D) 693 
Similar experiments show the effects of carbachol (20 μM) on the peak increase in [Ca2+]c 694 
after the indicated combinations of treatments for 1 min (PTH(1-34)), 2 min (NKH477) or 5 695 
min (8-Br-cAMP) and 30 min. (E) Comparison of the relationship between cAMP and 696 
Δ[Ca2+]c for cells acutely stimulated with PTH(1-34) (1 min, n = 7), PTHrP(1-36) (1 min, n = 697 
3) or NKH477 (5 min, n = 8). (F, G) Relationships between cAMP and Δ[Ca2+]c for cells 698 
stimulated with carbachol (20 μM) after acute or sustained stimulation with PTH(1-34) (F) or 699 
NKH477 (G). Results are means ± s.e.m., n = 4 (A-D) or at least 3 (F, G). (H) Targets of the 700 
drugs used. 701 
 702 
Fig. 6. Neither acute nor sustained potentiation of carbachol-evoked Ca
2+
 signals 703 
requires activation of protein kinase A. (A-E) Cells were incubated with H89 (10 µM, 20 704 
min) to inhibit PKA before acute or sustained stimulation with PTH(1-34) (A, B), NKH477 705 
(C, D) or 8-Br-cAMP (10 mM) (E) followed by addition of carbachol (20 µM) in Ca
2+
-free 706 
HBS. Results show peak increases in [Ca
2+
]c evoked by carbachol as means ± s.e.m., n = 3. 707 
(F) Targets of the drugs used.  708 
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Fig. 7. Acute potentiation of carbachol-evoked Ca
2+
 signals via cAMP signalling 709 
junctions. (A, B) Cells were incubated with IBMX (1 mM, 5 min) before stimulation with 710 
PTH(1-34) for 1 min and then addition of carbachol (20 μM) in Ca2+-free HBS. Results show 711 
intracellular levels of cAMP (A) and the peak increases in [Ca
2+
]c evoked by carbachol (B).  712 
(C) Effects of IBMX (1 mM, 5 min) or SQ/DDA (1 mM SQ 22536 and 200 µM DDA, 20 713 
min) on the increase in intracellular cAMP concentration evoked by NKH477 (300 µM, 5 714 
min). (D) Targets of the drugs used. (E, F) Effects of similar treatments with IBMX of 715 
SQ/DDA on the peak Ca
2+
 signals evoked by carbachol (20 µM) after incubation with the 716 
indicated concentrations of NKH477 for 5 min. Results (A-E) are means ± s.e.m., n = 3. (G) 717 
Communication between PTH1R and IP3Rs is proposed to be mediated by local delivery of 718 
supramaximal concentrations of cAMP from AC to IP3Rs within junctional complexes. We 719 
suggest that the concentration-dependent effects of PTH are then mediated by recruitment of 720 
these all-or-nothing junctions, rather than from graded activity within each (Tovey et al., 721 
2008).  722 
 723 
Fig. 8.  Sustained potentiation of carbachol-evoked Ca
2+
 signals is mediated by cAMP 724 
junctions. (A) Effects of SQ/DDA and IBMX (concentrations as in Fig. 7C) on the increase 725 
in intracellular cAMP concentration evoked by NKH477 (300 µM, 15 min). (B, C) Effects of 726 
the same treatments on the peak Ca
2+
 signals evoked by carbachol (20 μM) after incubation 727 
for 15 min with the indicated concentrations of NKH477. (D, E) Similar analyses of the 728 
effects of SQ/DDA and/or IBMX on the increase in intracellular cAMP concentration evoked 729 
by incubation with the indicated concentrations of PTH(1-34) for 60 min (D) or the peak Ca
2+
 730 
signals evoked by carbachol (20 µM) added 60 min after PTH(1-34) (E). Results (A-E) are 731 
means ± s.e.m., n = 3. (F) Relationships between cAMP and Δ[Ca2+]c for cells stimulated 732 
with PTH(1-34) for 60 min alone or after treatment with SQ/DDA or IBMX (G) Normally 733 
cAMP is delivered to IP3R within signalling junctions (left panel), but massive accumulation 734 
of cAMP during sustained stimulation with PTH and IBMX (right panel) achieves global 735 
cytosolic cAMP concentrations sufficient to sensitize IP3R beyond active junctions. (H) 736 
Targets of the drugs used. 737 
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